当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 利润表

贝瑞基因

(000710)

  

流通市值:80.52亿  总市值:201.77亿
流通股本:1.42亿   总股本:3.55亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-06-302018-09-30
一、营业总收入369,973,449.871,617,641,301.4753,237,670.261,028,243,410.55
营业收入369,973,449.871,617,641,301.4753,237,670.261,028,243,410.55
二、营业总成本283,554,886.911,174,697,818.69542,621,045.95751,900,989.94
营业成本164,904,983.19628,802,382.96292,601,792.94429,016,280.67
营业税金及附加479,466.66,277,860.342,748,183.15,186,068.16
销售费用57,419,026.13299,040,471.53140,453,080.21184,527,432.95
管理费用27,660,646.32121,767,231.3954,998,712.5173,225,317.05
财务费用3,509,976.99-693,123.88-1,619,333.322,705,637.92
资产减值损失------1,374,380.24
三、其他经营收益--7,684,697.04344,006.052,794,207.24
允许价值变动净收益--------
投资净收益-13,836,212.0715,112,437.7570,847,271.42-1,210,308.75
联营、合营企业投资收益-14,737,800-81,011,321.45-22,802,968.08-7,210,308.75
汇兑净收益--------
四、营业利润71,853,716.53450,186,565.54280,139,221.07281,611,761.86
营业外收入709,129.64313,641.26582,767.58525,486.03
营业外支出525,856.054,831,772.1982,673.53396,403.8
非流动资产处置净损失--------
五、利润总额72,036,990.12445,668,434.61280,639,315.12281,740,844.09
所得税11,988,649.0758,538,131.9431,783,668.8243,964,839.9
未确认的投资损失--------
六、净利润(百万元)250.83167.69268.09238.99
少数股东损益-2,344,957.05-3,487,995.48-1,970,585.71-1,210,228.51
归属于母公司股东的净利润62,393,298.1390,618,298.15250,826,232.01238,986,232.7
七、每股收益----0.710.67
基本每股收益0.181.10.710.67
稀释每股收益0.181.10.710.67
TOP↑